A relaxin based nanoparticle treats liver fibrosis
PRIYANKA CHAKRABORTY, AMITY UNIVERSITY, KOLKATA Liver fibrosis is one of the leading causes of morbidity and mortality among human beings. The unavailability of proper antifibrotic therapy makes the disease more deadly and the patients more vulnerable. RLX ( peptide hormone human relaxin-2), acting through a G protein-coupled receptor relaxin peptide receptor 1 (RXFP1), promotes tissue […]